Newsletter #8
KinExA Concentration Measurements
The main use of KinExA technology is to determine tight affinities under physiologically relevant conditions but it can also be used for concentration immunoassays in a variety of sample matrices. This technique can be advantageous for many different applications; from serum and plasma measurements to environmental toxin detection.
In particular, therapeutic drug monitoring (TDM) is a practice that focuses on monitoring and sampling patient blood to determine drug concentrations in a clinical setting. It is believed that there is a definable relationship between dose and plasma/blood drug concentration, which is directly linked to therapeutic effects.1 While there are many factors that need to be taken into account when interpreting results, the ability to measure very low concentrations with KinExA can help researchers measure drug concentrations in an accurate and cost effective way.
In a recent publication,2 researchers measured the plasma concentration of Afatinib. The use of the KinExA for this measurement allowed for a lower limit of quantitation and better coefficient of variation when compared to other methods. A simpler procedure and convenience also supported the use of KinExA over conventional chromatographic assays.
In another study,3 the high sensitivity of KinExA employed the use of very small volumes (~1 μL) of plasma samples for analysis. Researchers also proposed that the high accuracy and automated analysis can be used to facilitate pharmacokinetics, pharmacodynamics, and TDM of therapeutic antibodies.
While the main use of KinExA is to determine affinity and kinetics, it is great to see researchers exploit the sensitivity and versatility of KinExA in a clinical setting.
- Kang, J. Lee, M. 2009. Overview of therapeutic drug monitoring. Korean J Intern Med. 24(1):1–10. doi:10.3904/kjm.200921.1.1
- Darwish, IA., et al. 2019. Development of two different formats of heterogeneous immunosensor. Scientific Reports 9:14742. https://doi.org/10.1038/s41598-019-51288-5.
- AlRabiah, H., et al. 2019. Automated flow fluorescent noncompetitive immunoassay for measurement of human plasma levels of monoclonal antibodies used for immunotherapy of cancers with KinExA 3200 biosensor. Talanta 192:331–338. doi:10.1016/j.talanta.2019.09.014.
Anti-His Secondary Antibody
The sensitivity of KinExA is attributed to the method of detection. This is why having a good fluorescent antibody is crucial. In some cases, the constant binding partner (CBP) is an IgG and detection is easily achieved with the use of commercially available fluorescent anti-species antibodies. In other cases, the CBP is a protein with purification tags such as biotin or histidine. A biotin-tagged protein is easily detected with fluorescent streptavidin. Labels for his-tagged proteins, however, have been expensive and quite inconsistent in their ability to effectively perform across different his tagged molecules. It is unclear why these antibodies bind differently, but it could be due to the location of the his-tag.
Over the years, we have tried a variety of anti-his antibodies for detecting his-tagged molecules. Where one seemed to work well for a particular his-tagged molecule, it failed to work with another. Recently, we tested SouthernBiotech’s Anti-His-Tag Antibody and, so far, it has proven to be a superior antibody at detecting his-tags.
For testing, Ubiquitin (N-terminal his-tag) or EGF (C-terminal his-tag) was coated onto beads. Anti-his antibodies, at a molecular concentration of 1 nM, were passed over the bead column and the fluorescent signal was measured. We also tested each antibody against an untagged mouse Fc column to check for any cross reactivity. Table 1 shows the results.
For both his-tagged molecules, the SouthernBiotech antibody was superior for detection and had low cross reactivity.

Since this label works so well in our lab, we want to make it easy for our customers to try as well. SouthernBiotech is willing to offer our customers a special 10% discount on their first order of anti-his label. To get the discount, use the coupon code “Sapidyne” at checkout. Discounts are eligible until March 31st, 2020. We hope you have as much success with this antibody as we have.
For more information regarding SouthernBiotech’s Anti-His Antibody, refer to www.southernbiotech.com/His-Tag.aspx.
Antibodies Tested
- SouthernBiotech Anti-His-Tag-Alexa Fluor® 647. Catalog # 4603-31.
- BioXCell ReadyTag Anti-6-His. Catalog #RT0266. Note: Primary labeled in house.
- BioLegend Purified Anti-His Tag Antibody. Catalog 652501. Note: Primary labeled in house.
- ThermoFisher Scientific 6x-His Tag Monoclonal Antibody (HIS.H8) Dylight 650. Catalog # MA1-21315-D650.
- ABM Anti-His Tag Antibody. Catalog #G020. Note: Primary labeled in house.
- BioRad Mouse Anti Histidine Tag. Catalog# MCA1396GA. Note: Primary labeled in house.
Spotlight
KinExA Manual Available Online
We are excited to announce that the KinExA Manual is now available on our website! It covers every KinExA instrument to help you get the most out of your research.
The manual provides instrument overviews, a thorough introduction of KinExA Pro Software, details of data analysis, experiment setup/tutorials, and hyperlinks to popular tech-notes and how-to-guides.
Visit sapidyne.com/kinexa-manual to download.
KinExA Enters Korea with GREENics

In an effort to spread KinExA knowledge and to help better serve users in the region, we are pleased to announce our partnership with GREENics. GREENics is the exclusive KinExA dealer for Korea and instruments are now available for purchase or rental in the country.
GREENics was founded in 1983 and, during the last 36 years, has focused on supplying and servicing products to various industries and educational institutes. They are one of the largest distributors of scientific and analytical instruments in Korea. Part of their success comes from a sincere commitment to customer satisfaction that ensures both quality support and innovation, which aligns well with Sapidyne’s business philosophy.
This new partnership will help spread our industry-leading sensitivity throughout Korea and bring solution-phase affinity, kinetics, and concentration analysis to researchers within the country.








